EMPLOYMENT AGREEMENTEmployment Agreement • November 13th, 2013 • Novelos Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 13th, 2013 Company Industry JurisdictionThis AGREEMENT is made as of the 4th day of October, 2013, by and between Novelos Therapeutics, Inc., a Delaware corporation, with its principal executive offices in Newton, Massachusetts and principal offices in Madison, Wisconsin (the “Company”), and Simon Pedder of Fort Mill, South Carolina (the “Executive”).
EXECUTIVE RETENTION AGREEMENTExecutive Retention Agreement • November 13th, 2013 • Novelos Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledNovember 13th, 2013 Company Industry JurisdictionThis AGREEMENT is made as of July 26, 2013 (the “Effective Date”), by and between Novelos Therapeutics, Inc., a Delaware corporation (the “Company”), with its executive offices located at One Gateway Center, Suite 504, Newton, Massachusetts 02458, and Dr. Christopher J. Pazoles (the “Employee”).
CONSULTING AGREEMENTConsulting Agreement • November 13th, 2013 • Novelos Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 13th, 2013 Company Industry JurisdictionThis AGREEMENT is made as of the 4th day of October, 2013, by and between Novelos Therapeutics, Inc., a Delaware corporation, with its principal executive offices in Newton, Massachusetts and principal offices in Madison, Wisconsin (the “Company”), and Simon Pedder of Fort Mill, South Carolina (the “Consultant”).
THIRD AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • November 13th, 2013 • Novelos Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledNovember 13th, 2013 Company Industry JurisdictionThis AMENDMENT TO EMPLOYMENT AGREEMENT is made as of the 26th day of July, 2013 by and between Novelos Therapeutics, Inc., a Delaware corporation, with executive offices in Newton, Massachusetts (the “Company”), and Harry S. Palmin of Boston, Massachusetts (the “Executive”).